3/27
07:42 am
adct
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
Medium
Report
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
3/27
07:30 am
adct
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update
Medium
Report
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update
3/25
05:30 pm
adct
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
Low
Report
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
3/20
07:15 am
adct
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
Medium
Report
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
3/7
11:23 am
adct
ADC Therapeutics SA (NYSE: ADCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
ADC Therapeutics SA (NYSE: ADCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
2/24
08:20 am
adct
ADC Therapeutics SA (NYSE: ADCT) had its price target raised by analysts at Stephens from $6.00 to $8.00. They now have an "overweight" rating on the stock.
Medium
Report
ADC Therapeutics SA (NYSE: ADCT) had its price target raised by analysts at Stephens from $6.00 to $8.00. They now have an "overweight" rating on the stock.
2/3
04:05 pm
adct
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Medium
Report
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
1/30
07:53 am
adct
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference [Yahoo! Finance]
Medium
Report
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference [Yahoo! Finance]
1/30
07:15 am
adct
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
Medium
Report
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
1/6
08:14 am
adct
ADC Therapeutics SA (NYSE: ADCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
ADC Therapeutics SA (NYSE: ADCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
1/2
04:05 pm
adct
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Low
Report
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
12/30
04:30 pm
adct
ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma
Low
Report
ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma